Insider · CIK 0001746251

Dreyer Scott

Reports to the SEC for 1 company · STOUGHTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001746251

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-03	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	EVP & Chief Commercial Officer	SSale	−46.4K sh	$40.36	−$1.87M	75,329
2026-03-03	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	EVP & Chief Commercial Officer	SSale	−3,559 sh	$40.99	−$146K	71,770
2026-02-10	COLLCOLLEGIUM PHARMACEUTICAL, INCF Tax Payment	EVP & Chief Commercial Officer	FTax Payment	−21.6K sh	$46.75	−$1.01M	121,746
2026-02-10	COLLCOLLEGIUM PHARMACEUTICAL, INCA Award	EVP & Chief Commercial Officer	AAward	+19K sh	—	—	122,636
2026-02-10	COLLCOLLEGIUM PHARMACEUTICAL, INCA Award	EVP & Chief Commercial Officer	AAward	+30.7K sh	—	—	153,338
2026-02-10	COLLCOLLEGIUM PHARMACEUTICAL, INCF Tax Payment	EVP & Chief Commercial Officer	FTax Payment	−9,977 sh	$46.75	−$466K	143,361
2025-12-08	COLLCOLLEGIUM PHARMACEUTICAL, INCM Exercise/Conversion	EVP & Chief Commercial Officer	MExercise/Conversion	+17.6K sh	$15.90	+$280K	121,213
2025-12-08	COLLCOLLEGIUM PHARMACEUTICAL, INC · Stock Option (Right to Purchase)M Exercise/Conversion	EVP & Chief Commercial Officer	MExercise/Conversion	−17.6K sh	—	—	0
2025-12-08	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	EVP & Chief Commercial Officer	SSale	−6,475 sh	$48.66	−$315K	103,613
2025-12-08	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	EVP & Chief Commercial Officer	SSale	−11.1K sh	$47.89	−$533K	110,088
2025-08-18	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	EVP & Chief Commercial Officer	SSale	−16.4K sh	$38.21	−$626K	103,613
2025-08-18	COLLCOLLEGIUM PHARMACEUTICAL, INC · Stock Option (Right to Purchase)M Exercise/Conversion	EVP & Chief Commercial Officer	MExercise/Conversion	−16.4K sh	—	—	0
2025-08-18	COLLCOLLEGIUM PHARMACEUTICAL, INCM Exercise/Conversion	EVP & Chief Commercial Officer	MExercise/Conversion	+16.4K sh	$21.34	+$350K	120,002
2025-08-13	COLLCOLLEGIUM PHARMACEUTICAL, INC · Stock Option (Right to Purchase)M Exercise/Conversion	EVP & Chief Commercial Officer	MExercise/Conversion	−4,861 sh	—	—	16,389
2025-08-13	COLLCOLLEGIUM PHARMACEUTICAL, INCM Exercise/Conversion	EVP & Chief Commercial Officer	MExercise/Conversion	+4,861 sh	$21.34	+$104K	108,474
2025-08-13	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	EVP & Chief Commercial Officer	SSale	−4,861 sh	$38.03	−$185K	103,613
2025-03-21	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	EVP & Chief Commercial Officer	SSale	−18.9K sh	$30.03	−$567K	103,613
2025-03-20	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	EVP & Chief Commercial Officer	SSale	−1,927 sh	$30.00	−$57.8K	122,494
2025-03-14	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	EVP & Chief Commercial Officer	SSale	−2,255 sh	$30.00	−$67.7K	124,421
2025-03-11	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	EVP & Chief Commercial Officer	SSale	−15.4K sh	$30.00	−$462K	126,676
2025-03-07	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	EVP & Chief Commercial Officer	SSale	−2,348 sh	$30.00	−$70.4K	142,063
2025-03-06	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	EVP & Chief Commercial Officer	SSale	−3,295 sh	$30.00	−$98.9K	144,411
2025-03-06	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	EVP & Chief Commercial Officer	SSale	−15.4K sh	$30.00	−$462K	126,676
2025-02-10	COLLCOLLEGIUM PHARMACEUTICAL, INCA Award	EVP & Chief Commercial Officer	AAward	+26.4K sh	—	—	177,329
2025-02-10	COLLCOLLEGIUM PHARMACEUTICAL, INCF Tax Payment	EVP & Chief Commercial Officer	FTax Payment	−7,953 sh	$30.52	−$243K	169,376
2025-02-10	COLLCOLLEGIUM PHARMACEUTICAL, INCF Tax Payment	EVP & Chief Commercial Officer	FTax Payment	−21.7K sh	$30.52	−$661K	147,706
2025-02-10	COLLCOLLEGIUM PHARMACEUTICAL, INCA Award	EVP & Chief Commercial Officer	AAward	+45K sh	—	—	150,918
2024-05-24	COLLCOLLEGIUM PHARMACEUTICAL, INCM Exercise/Conversion	EVP & Chief Commercial Officer	MExercise/Conversion	+23.8K sh	$24.03	+$572K	162,709
2024-05-24	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	EVP & Chief Commercial Officer	SSale	−56.8K sh	$33.98	−$1.93M	105,902
2024-05-24	COLLCOLLEGIUM PHARMACEUTICAL, INC · Stock Option (Right to Purchase)M Exercise/Conversion	EVP & Chief Commercial Officer	MExercise/Conversion	−23.8K sh	—	—	0
2024-05-23	COLLCOLLEGIUM PHARMACEUTICAL, INCM Exercise/Conversion	EVP & Chief Commercial Officer	MExercise/Conversion	+51.2K sh	$24.03	+$1.23M	190,127
2024-05-23	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	EVP & Chief Commercial Officer	SSale	−51.2K sh	$33.82	−$1.73M	138,918
2024-05-23	COLLCOLLEGIUM PHARMACEUTICAL, INC · Stock Option (Right to Purchase)M Exercise/Conversion	EVP & Chief Commercial Officer	MExercise/Conversion	−51.2K sh	—	—	23,791
2024-02-26	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	EVP & Chief Commercial Officer	SSale	−9,336 sh	$36.38	−$340K	139,582
2024-02-26	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	EVP & Chief Commercial Officer	SSale	−664 sh	$37.15	−$24.7K	138,918
2024-02-12	COLLCOLLEGIUM PHARMACEUTICAL, INCF Tax Payment	EVP & Chief Commercial Officer	FTax Payment	−10.1K sh	$33.70	−$342K	148,918
2024-02-12	COLLCOLLEGIUM PHARMACEUTICAL, INCA Award	EVP & Chief Commercial Officer	AAward	+32.3K sh	—	—	178,608
2024-02-12	COLLCOLLEGIUM PHARMACEUTICAL, INCF Tax Payment	EVP & Chief Commercial Officer	FTax Payment	−19.5K sh	$33.70	−$659K	159,063
2024-02-12	COLLCOLLEGIUM PHARMACEUTICAL, INCA Award	EVP & Chief Commercial Officer	AAward	+35K sh	—	—	146,322
2024-01-16	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	EVP & Chief Commercial Officer	SSale	−23.6K sh	$32.28	−$761K	111,322
2023-03-01	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	EVP & Chief Commercial Officer	SSale	−13.3K sh	$26.70	−$356K	134,882
2023-02-10	COLLCOLLEGIUM PHARMACEUTICAL, INCA Award	EVP & Chief Commercial Officer	AAward	+44.3K sh	—	—	147,073
2023-02-10	COLLCOLLEGIUM PHARMACEUTICAL, INCA Award	EVP & Chief Commercial Officer	AAward	+22.5K sh	—	—	169,532
2023-02-10	COLLCOLLEGIUM PHARMACEUTICAL, INCF Tax Payment	EVP & Chief Commercial Officer	FTax Payment	−14.5K sh	$26.75	−$389K	155,003
2023-02-10	COLLCOLLEGIUM PHARMACEUTICAL, INCF Tax Payment	EVP & Chief Commercial Officer	FTax Payment	−6,797 sh	$26.75	−$182K	148,206
2023-01-09	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	EVP & Chief Commercial Officer	SSale	−10.4K sh	$27.08	−$282K	110,208
2023-01-09	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	EVP & Chief Commercial Officer	SSale	−7,341 sh	$27.83	−$204K	102,867
2023-01-09	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	EVP & Chief Commercial Officer	SSale	−69 sh	$28.58	−$1,972.02	102,798
2022-07-11	COLLCOLLEGIUM PHARMACEUTICAL, INCF Tax Payment	EVP & Chief Commercial Officer	FTax Payment	−594 sh	$17.48	−$10.4K	120,632
2022-02-18	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	EVP & Chief Commercial Officer	SSale	−10.6K sh	$21.61	−$228K	121,226

Recent filings

Accepted (ET)
Mar 54
Dreyer Scott0001746251-26-000004
SEC(opens sec.gov)
Feb 124
Dreyer Scott0001746251-26-000002
SEC(opens sec.gov)
Dec 104
Dreyer Scott0001746251-25-000004
SEC(opens sec.gov)
Aug 204
Dreyer Scott0001062993-25-014766
SEC(opens sec.gov)
Aug 154
Dreyer Scott0001062993-25-014526
SEC(opens sec.gov)
Mar 244
Dreyer Scott0001062993-25-006148
SEC(opens sec.gov)
Mar 184
Dreyer Scott0001062993-25-005752
SEC(opens sec.gov)
Mar 184/A
Dreyer Scott0001062993-25-005834
SEC(opens sec.gov)

Companies

COLLEGIUM PHARMACEUTICAL, INCEVP & Chief Commercial OfficerCOLL

Address

C/O COLLEGIUM PHARMACEUTICAL, INC. 100 TECHNOLOGY CENTER DRIVE

STOUGHTON, MA, 02072